86 participants
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-10
- Start Date:
- 2021-06-07
- Completion:
- 2022-12-31
Conditions
- Advanced or Metastatic Biliary Tract Cancer
Interventions
- DRUG
No Results Yet